News Results

There are 721,952 News Results

Dec 4, 2024
Introducing XREAL One Series: World's First Cinematic AR Glasses with X1 Independent Spatial Computing Chip for Complete Spatial Screen Control
Delivering a consistent three degrees-of-freedom cinematic spatial display from virtually any device, XREAL One Series features XREAL's first silicon chip called X1, a fully redesigned optical engine, adjustable interpupillary distance...
Dec 4, 2024
Immersion Cooling Market to grow by USD 988 Million (2024-2028), driven by rising data center investments, Report on how AI drives market transformation - Technavio
NEW YORK, Dec. 4, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global immersion cooling market size is estimated to grow by USD 988 million...
Dec 5, 2024
Enterprise Mobility Management (EMM) Market to grow by USD 75.37 Billion from 2024-2028, driven by BYOD adoption and AI impact on market trends - Technavio
NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global enterprise mobility management (EMM) market size is estimated to grow by USD...
Dec 15, 2024
Voice Evacuation Systems Market to grow by USD 1.1 Billion (2024-2028), driven by real estate and construction growth, Report with AI-powered insights - Technavio
NEW YORK, Dec. 15, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global voice evacuation systems market size is estimated to grow by USD 1.1...
Dec 19, 2024
HOME AFFORDABILITY WORSENS AGAIN ACROSS U.S. IN FOURTH QUARTER AS HOME PRICES KEEP CLIMBING
Major Home-Ownership Expenses Consume 34 Percent of National Average Wage;
Dec 20, 2024
FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors
-- FDA approval is based on data from the pivotal phase 3 trial (explorer7) establishing the safety and efficacy of Alhemo(®) for daily prevention of bleeds in adults and pediatric...
Jan 7, 2025
Soul App and Fudan University's Center for Communication and State Governance Research Unveil 2025 Social Trend Keywords: Embracing the Era of Self-Pleasure and Enchanting the World
SHANGHAI, Jan. 7, 2025 /PRNewswire/ -- Chinese Gen Z is embarking on an unparalleled quest for self-exploration. In a world that is growing ever more dynamic, this generation is seeking...
Jan 7, 2025
Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference
LUND, Sweden, Jan. 7, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43(rd) Annual J.P. Morgan Healthcare Conference....
Jan 8, 2025
NOTICE OF DATA BREACH
LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community: Stiiizy, Inc. ("STIIIZY") values the trust you place in us and takes the privacy and security of...
Jan 9, 2025
Servier Announces Expansion of its Tibsovo (ivosidenib) Development Program Investigating its Safety and Efficacy in Patients Living with IDH1-Mutated Cancers in Both Hematological Malignancies and Solid Tumors
-- First patient enrolled in the Phase 3 CHONQUER clinical trial in patients with IDH1-mutant conventional chondrosarcoma -- Phase 3 PyramIDH clinical trial in patients with IDH1-mutant myelodysplastic syndromes has...
72196

Pages

1

Stories of the day

Sep 25, 2025
Boeing to Relocate F/A-18 Service Life Modification Work to Support St. Louis...
Sep 25, 2025
Integrated Battle Command System Achieves Major Milestone with First Successful...
Sep 25, 2025
RTXs Raytheon and Avio USA expand collaboration to accelerate Mk 104 rocket...
Sep 26, 2025
Latvia orders Rheinmetall ammunition factory – Group expands global ammunition...